Pancreatic Cancer Research

ResearcherHebrew University of JerusalemNo recent work listed

Eithan Galun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6243-6702; OpenAlex author ID A5090206769. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper

Papers 2

  1. RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients. Last author DOI 10.18632/oncotarget.4183↗
  2. Mutant KRAS is a druggable target for pancreatic cancer. Last author DOI 10.1073/pnas.1314307110↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Talia Golan · 2 shared papers, 2013–2015 · strength 0.07
  2. Elina Zorde Khvalevsky · 2 shared papers, 2013–2015 · strength 0.07
  3. Ayala Hubert · 2 shared papers, 2013–2015 · strength 0.07
  4. Amiel Segal · 1 shared paper, 2015 · strength 0.04
  5. Abed Khalaileh · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.